No company in its right mind would risk a large private market for this outcome?

Can the government, its officials, and an advisory committee, whose sole responsibility is the public market, realistically expect companies to compromise or risk their larger, more lucrative private markets for a controlled, less commercially attractive public reimbursement? Is our public payer capable of recognising this reality and of compromise? …